Cargando…
FRI516 Low Dose Methimazole Induced Isolated Thrombocytopenia
Disclosure: F. Amer: None. S. Ghaith: None. S. Kadiyala: None. M. Xhikola: None. Background: Thionamides can lead to agranulocytosis in 0.1 - 0.5% of patients. This is a severe adverse reaction due to inhibition of myelopoiesis. The proposed mechanism of bone marrow suppression is thought to be due...
Autores principales: | Amer, Farah, Ghaith, Sarah, Kadiyala, Sushma, Xhikola, Majlinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553538/ http://dx.doi.org/10.1210/jendso/bvad114.1861 |
Ejemplares similares
-
Papillary Thyroid Carcinoma Within Thyroglossal Duct Cyst
por: Anbari, Raghda Al, et al.
Publicado: (2021) -
FRI505 A Rare Case Of Methimazole Induced Grave Agranulocytosis
por: Barua, Nabonita, et al.
Publicado: (2023) -
FRI511 Bexarotene: A Deceptive Cause Of Iatrogenic Hypothyroidism
por: Ghaith, Sarah, et al.
Publicado: (2023) -
SAT-516 A Severe Case of Pembrolizumab-Induced Thyroiditis
por: Lane, Kyrstin, et al.
Publicado: (2020) -
SAT-625 Dose-Dependent, Methimazole-Induced Agranulocytosis in a Pregnant Hispanic Woman with Grave's Disease
por: Bello, Fatimah, et al.
Publicado: (2019)